Zanchetti, A, Liu, L, Mancia, G, Parati, G, Grassi, G, Stramba-Badiale, M, Silani, V, Bilo, G, Corrao, G, Zambon, A
, Scotti, L, Zhang, X, Guan, TR, Zhang, Y, Zhang, X, Berge, E, Redon, J, Narkiewicz, K, Dominiczak, A, Nilsson, P, Viigimaa, M, Laurent, S, Agabiti-Rosei, E, Wu, Z, Zhu, D, Rodicio, JL, Ruilope, LM, Martell-Claros, N, Pinto, F, Schmieder, RE, Burnier, M, Banach, M, Cifkova, R, Farsang, C, Konradi, A, Lazareva, I, Sirenko, Y, Dorobantu, M, Postadzhiyan, A, Accetto, R, Jelakovic, B, Lovic, D, Manolis, AJ, Stylianou, P, Dicker, D, Wei, G, Xu, C, Xie, H, Coca, A, O'Brien, J & Ford, G 2016, '
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke',
Journal of Hypertension, vol. 34, no. 3, pp. 393-396.
https://doi.org/10.1097/HJH.0000000000000853